跳至主要内容
临床试验/EUCTR2016-001108-47-ES
EUCTR2016-001108-47-ES进行中(未招募)1 期

Impact of eradication of asymptomatic bacteriuria on reducing the incidence of early infection in patients with periprosthetic femoral fractures requiring hip hemiarthroplasty - BARIFER

Fundació Hospital Universitari Vall Hebron-Institut de Recerca (VHIR)0 个研究点目标入组 1,394 人开始时间: 2016年4月20日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
1,394

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Age ?18 years.
  • 2.Femur fracture patients diagnosed at the participating centers, requiring hip hemiarthroplasty.
  • 3.Properly informed and give their written consent to participate in the study and undergo tests and examinations that entails.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 1394
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 1394

排除标准

  • 1.Febrile patients (axillary temperature> 38 ° C).
  • 2.Patients with sugestive symptoms of active urinary tract infection (urinary tract symptoms, macroscopic evidence of pyuria).
  • 3.Patients with any active infectious process requiring administration of antibiotic therapy.
  • 4.Patients who had not been possible the collection of a urine sample to take a urine culture.
  • 5.Patients with a history of intolerance or allergic fosfomycin-trometamol.
  • 6.Impossibility for patients with oral intake.
  • 7.Expectation of life less than 3 months.

研究者

发起方
Fundació Hospital Universitari Vall Hebron-Institut de Recerca (VHIR)

相似试验